Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer

Open Access
Publisher Website
Google Scholar
Abstract
Assessment of total plasma DNA can be a promising noninvasive tool for monitoring the effect of cytotoxic therapies in order to predict therapeutic efficacy at an early stage.